Trials and PIsView all posts »
Symplicity HTN-2 with Dr Murray EslerNov 17, 2010 13:10 EST
Dr Murray Esler (IDI Heart and Diabetes Institute, Melbourne, Australia) discusses Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension with Dr Gabriel Steg.
Filmed during AHA 2010 in Chicago, IL on November 14.
A revolutionary road for resistant hypertension? Renal denervation in Symplicity HTN-2